Lactulose may support people with hepatic encephalopathy by reducing ammonia production in the gut, converting ammonia into forms that are more easily eliminated, and increasing bowel movements to remove ammonia from the body. Together, these effects can help improve mental status and cognitive function, and reduce the risk of recurrent HE episodes. Lactulose is an established, standard first-line treatment for hepatic encephalopathy. The extent of benefit varies from person to person, depending on liver condition, the severity and frequency of past HE episodes, and how well the body responds to therapy.
Lactulose is not always used on its own. For patients who continue to have recurrent HE episodes, healthcare providers may add rifaximin (Xifaxan), an antibiotic that complements lactulose by reducing ammonia-producing bacteria in the gut.
As with any medication, lactulose may cause side effects, most often related to its effect on digestion. Your healthcare provider will monitor your mental status, bowel movement frequency, hydration, and electrolyte balance throughout treatment, and will help you adjust the dose if bowel movements become too frequent or infrequent.